Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Health Affairs (Project Hope)|August 3, 2026
The Economics Of Orphan Blockbuster Drug DevelopmentJennifer C Chen, Chris Madsen, Anna KaltenboeckValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Pharmaceutical Products and Their Value: Lessons Learned and the Path AheadAnna KaltenboeckThe American Journal of Managed Care|June 8, 2026
Under the magnifying glass: a wave of drug price transparencyMary Gens, Anna KaltenboeckAMA Journal of Ethics|August 10, 2019
Evolving Medicaid Coverage Policy and RebatesJennifer A Ohn, Anna KaltenboeckJournal of Comparative Effectiveness Research|August 24, 2021
Potential policy reforms to strengthen the accelerated approval pathwayAnna Kaltenboeck, Amanda Mehlman, Steven D PearsonThe Milbank Quarterly|March 8, 2022
Compulsory Licensing of Pharmaceuticals in High-Income Countries: A Comparative AnalysisLindor Qunaj, Anna Kaltenboeck, Peter B BachMedical Science Educator|August 30, 2021
Priceless Knowledge: Attitudes and Awareness Around Drug Pricing Among US Medical StudentsDeborah Korenstein, Anna Kaltenboeck, Maha Mamoor, et al.BMC Medical Education|July 25, 2021
The future of physician advocacy: a survey of U.S. medical studentsSusan Chimonas, Maha Mamoor, Anna Kaltenboeck, et al.The American Journal of Managed Care|January 23, 2016
Care pathways in US healthcare settings: current successes and limitations, and future challengesAnita Chawla, Kimberly Westrich, Susanna Matter, et al.Expert Review of Clinical Pharmacology|October 24, 2013
Assessing the impact of substandard copy medicines in developing countries: the experience with imatinib copiesAnna Kaltenboeck, Genia Long, Eleanor Hayes-Larson, et al.Pageof 6